PET probes beyond 18F-FDG

被引:3
作者
Lei Jiang [1 ,2 ]
Yingfeng Tu [2 ]
Hongcheng Shi [1 ]
Zhen Cheng [2 ]
机构
[1] Department of Nuclear Medicine,Zhongshan Hospital,Fudan University
[2] Molecular Imaging Program at Stanford(MIPS),Department of Radiology,Stanford Cancer Institute,Bio-X Program,Canary Center at Stanford for Cancer Early Detection,Stanford University
关键词
PET; molecular probes; personalized medicine;
D O I
暂无
中图分类号
R816 [各部位及各科疾病的X线诊断与疗法];
学科分类号
1001 ; 100105 ; 100207 ; 100602 ;
摘要
During the past several decades,positron emission tomography(PET) has been one of the rapidly growing areas of medical imaging;particularly,its applications in routine oncological practice have been widely recognized.At present,F-fluorodeoxyglucose(F-FDG) is the most broadly used PET probe.However,F-FDG also suffers many limitations.Thus,scientists and clinicians are greatly interested in exploring and developing new PET imaging probes with high affinity and specificity.In this review,we briefly summarize the representative PET probes beyondF-FDG that are available for patients imaging in three major clinical areas(oncology,neurology and cardiology),and we also discuss the feasibility and trends in developing new PET probes for personalized medicine.
引用
收藏
页码:435 / 446
页数:12
相关论文
共 50 条
  • [21] 18F-FDG PET/CT in the Evaluation of Polyarteritis Nodosa
    Brown, Parker J.
    Huang, Steve
    Martinez, Felipe
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (12) : E682 - E684
  • [22] 18F-FDG PET/CT and MRI of Necrobiotic Xanthogranuloma
    Ba Duong Nguyen
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (01) : E101 - E103
  • [23] The role of 18F-FDG PET/CT radiomics in lymphoma
    Rizzo, Alessio
    Triumbari, Elizabeth Katherine Anna
    Gatta, Roberto
    Boldrini, Luca
    Racca, Manuela
    Mayerhoefer, Marius
    Annunziata, Salvatore
    CLINICAL AND TRANSLATIONAL IMAGING, 2021, 9 (06) : 589 - 598
  • [24] 18F-FDG PET/CT Imaging of Adrenal Liposarcoma
    Wang, Rang
    Fan, Qiuping
    Tian, Rong
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (07) : 570 - 571
  • [25] Assessment criteria for 18F-FDG PET during immunotherapy
    Hamdan, D.
    Anjorand, E.
    Bousquet, G.
    Soussan, M.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2024, 48 (06): : 279 - 286
  • [26] Ochronosis Involvement and Extensity With 18F-FDG PET/CT
    Acar, Emine
    Bekis, Recep
    Zengin, Berin
    Birlik, Merih
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (05) : E360 - E361
  • [27] Characterizing POEMS Syndrome with 18F-FDG PET/CT
    Pan, Qingqing
    Li, Jian
    Li, Fang
    Zhou, Daobin
    Zhu, Zhaohui
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (09) : 1334 - 1337
  • [28] Comparison of 18F-FDG and PiB PET in Cognitive Impairment
    Lowe, Val J.
    Kemp, Bradley J.
    Jack, Clifford R., Jr.
    Senjem, Matthew
    Weigand, Stephen
    Shiung, Maria
    Smith, Glenn
    Knopman, David
    Boeve, Bradley
    Mullan, Brian
    Petersen, Ronald C.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (06) : 878 - 886
  • [29] Characterization of 'cold' vertebrae on 18F-FDG PET/CT
    Jaimini, Abhinav
    D'Souza, Maria M.
    Seniaray, Nikhil
    Sharma, Harshul
    Arbind, Arpana
    Sharma, Rajnish
    Mondal, Anupam
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (01) : 30 - 42
  • [30] 18F-FDG PET/CT in Tumefactive Multiple Sclerosis
    Maffione, Anna Margherita
    Rampin, Lucia
    Grassetto, Gaia
    L'Erario, Roberto
    Colletti, Patrick M.
    Rubello, Domenico
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (08) : 750 - 751